Nitrogenous organic acid synthesized endogenously from Arginine, glycine, and Methionine (requiring S-adenosylmethionine for final methylation step), functioning as the body's most rapid ATP regeneration buffer via the phosphocreatine shuttle system. Acts primarily as an ergogenic aid in muscle tissue (~95% storage) with emerging neuroprotective roles in brain (~5% storage), exhibiting responder variability—approximately 30% of individuals show minimal response due to pre-saturated stores.
Think of creatine as an emergency battery pack strapped to every worker in a power plant. When the main grid (ATP) gets depleted faster than the generators (mitochondria) can produce new electricity, these battery packs (phosphocreatine) instantly donate their stored charge to dead batteries (ADP), converting them back to working ones (ATP) in milliseconds—far faster than waiting for the generators to fire up or the backup diesel (glycolysis) to kick in. The system works like this: during rest periods, workers charge up their battery packs using excess power from the main grid. When a sudden surge in demand hits—like a factory suddenly switching on all machines (high-intensity exercise)—the battery packs discharge immediately, keeping operations running without a flicker. In vegetarians, it's as if the workers never got issued full battery packs to begin with, so when they finally do (through supplementation), the performance improvement is dramatic. Non-responders are workers whose packs are already fully charged—giving them more batteries does nothing because the storage lockers are full.
- Kidney: Arginine + glycine → Guanidinoacetate (via L-arginine:glycine amidinotransferase/AGAT)
- Liver: Guanidinoacetate + SAM-e → Creatine + S-adenosylhomocysteine (via guanidinoacetate N-methyltransferase/GAMT)
- This step consumes ~40% of all SAM-e in the body, making creatine synthesis a major drain on methylation capacity
- Competes with other methylation demands (neurotransmitter synthesis, DNA methylation, phospholipid production)
- Transport: Creatine enters cells via creatine transporter (CRT/SLC6A8) using Na⁺-Cl⁻ co-transport
The Creatine Kinase Reaction (reversible):
Phosphocreatine + ADP + H⁺ ↔ Creatine + ATP
Forward reaction (ATP regeneration):
- Occurs during high energy demand (muscle contraction, neuronal firing)
- Catalyzed by creatine kinase (CK) isoforms:
- CK-MM (muscle)
- CK-BB (brain)
- CK-MB (heart)
- Mitochondrial CK (mtCK) in intermembrane space
- Response time: 1-10 milliseconds (vs. glycolysis: seconds; Oxidative Phosphorylation: minutes to upregulate fully)
Reverse reaction (phosphocreatine charging):
- Occurs during rest when ATP:ADP ratio is high
- Stores energy as phosphocreatine for later use
graph TD
A[Mitochondrial ATP production] -->|mtCK| B[Phosphocreatine in intermembrane space]
B -->|Diffuses rapidly| C[Cytoplasmic phosphocreatine pool]
C -->|Cytoplasmic CK| D[ATP at sites of use]
D -->|ADP returns| C
C -->|Creatine returns| B
E[High energy demand site] -->|Depletes ATP| D
D -->|Phosphocreatine buffer responds| F[Instant ATP regeneration]
G[ADP accumulation] -->|Prevented by creatine system| H[No feedback inhibition of ATPases]
- ADP Buffering: By rapidly removing ADP, prevents product inhibition of ATPases (maintains force production during sustained contraction)
- Phosphate Shuttling: Transfers high-energy phosphate from mitochondria (production site) to cytoplasm (utilization site) more efficiently than ATP diffusion alone
- Proton Buffering: Consuming H⁺ during phosphocreatine breakdown helps buffer lactic acid accumulation during anaerobic work
- Neuroprotection: Maintains neuronal ATP during metabolic stress → prevents excitotoxicity, supports antioxidant defenses, stabilizes mitochondrial membrane potential
- Gene Expression: Creatine availability influences AMPK signaling, mitochondrial biogenesis markers (PGC-1α), and myogenic transcription factors
- Spontaneous, non-enzymatic conversion to creatinine (~1.7% daily of total creatine pool)
- Creatinine excreted renally (used clinically to estimate muscle mass and kidney function)
- Daily turnover: ~2g in 70kg individual
- Requires replacement through diet (~1g/day in omnivores) or synthesis (~1g/day endogenous)
High-intensity performance: Creatine is the intervention of choice when work bouts last <30 seconds and involve maximal effort (weightlifting, sprinting, jumping). The phosphocreatine system dominates energy supply in this window—supplementation increases the depth of this buffer by 20-40%. Exam connection: This maps to Metamodel 1 (energy distribution) and the concept of metabolic flexibility—creatine expands the capacity of the fastest energy system.
Vegetarian/vegan populations: Baseline muscle creatine is 20-30% lower in those consuming no meat (sole dietary source). Supplementation in this group produces the most dramatic responses—strength gains of 8-10% vs. 3-5% in omnivores. This is evolutionary mismatch: the Hunter-Gatherer Phenotype consumed ~1-2g creatine daily from meat; modern plant-based diets provide zero, forcing maximal endogenous synthesis and draining methylation capacity.
Brain energy metabolism: Emerging evidence for cognitive benefits, particularly under stress (sleep deprivation, hypoxia, traumatic brain injury). The brain operates near its ATP ceiling constantly—creatine supplementation increases this ceiling, providing reserve capacity during metabolic challenges. Relevant in post-concussion protocols, chronic fatigue syndrome, and Long COVID where brain energy metabolism is compromised.
Mitochondrial support in inflammation: Chronic inflammation impairs mitochondrial function through TNF-α and IL-1β effects on Oxidative Phosphorylation. Creatine provides an ATP bypass route when mitochondrial production is sluggish—clinically relevant in autoimmune conditions, chronic pain (where neuroinflammation impairs neuronal energy), and sarcopenia.
Methylation interaction: Because creatine synthesis consumes ~40% of SAM-e, supplementing creatine spares methylation capacity for other critical processes (neurotransmitter synthesis, DNA methylation, myelin maintenance). In patients with MTHFR polymorphisms or methylation deficiency, creatine supplementation may indirectly support cognitive function, mood, and detoxification.
Non-responders (~30% of population):
- Already have saturated muscle creatine stores (>150 mmol/kg dry weight)
- Typically meat-eaters with high dietary creatine intake
- May have genetic variations in CRT (creatine transporter)
- Still may benefit from brain/neuroprotection effects even if muscle performance doesn't improve
Responders (~70%):
- Baseline stores <140 mmol/kg
- Vegetarians/vegans almost universally respond
- Show 8-20% increases in muscle creatine content
- Performance gains: 5-15% in high-intensity work capacity
Loading phase (optional):
- 20g/day (4 × 5g doses) for 5-7 days
- Saturates stores rapidly
- May cause GI distress or water retention in some individuals
Maintenance phase (standard):
- 3-5g/day continuous
- Achieves saturation in 3-4 weeks without loading
- Preferred for long-term use
- Can be taken any time of day (timing doesn't matter for saturation effects)
Special populations:
- Vegetarians: May benefit from 5g/day maintenance (higher dose needed to overcome zero dietary intake)
- Aging (>50 years): 5g/day recommended (declining endogenous synthesis with age)
- TBI/concussion: 10-20g/day acutely may provide neuroprotection (emerging evidence)
- Long-term studies (up to 5 years) show no adverse renal, hepatic, or hormonal effects in healthy individuals
- Kidney concern myths: Creatinine (breakdown product) increases but GFR remains stable—not nephrotoxic
- Slight water retention (1-2kg) in first week due to osmotic draw into muscle cells—not "fat gain"
- No evidence of hair loss despite internet claims (no DHT interaction)
- Safe in adolescents, pregnancy (limited data), elderly
- Normal muscle creatine: 120-140 mmol/kg dry weight
- Post-supplementation saturation: 140-160 mmol/kg
- Brain creatine (spectroscopy): 5-10 mmol/kg wet weight
- Plasma creatine peak: 1-2 hours post-dose
- Serum creatinine increase: ~10-20% (not pathological)
- Creatine synthesis consumes approximately 40% of all SAM-e produced daily—making it the largest single methylation sink in the body
- Vegetarians have 20-30% lower baseline muscle creatine and universally respond to supplementation (unlike omnivores where 30% are non-responders)
- The phosphocreatine system regenerates ATP in 1-10 milliseconds, compared to glycolysis (seconds) and Oxidative Phosphorylation upregulation (minutes)
- Muscle stores ~95% of body creatine (~120g in 70kg person), brain ~5% (~5g)
- Daily turnover via spontaneous creatinine conversion: ~1.7% of total stores (approximately 2g/day)
- Loading dose (20g/day × 5-7 days) achieves saturation in 1 week vs. maintenance dose (3-5g/day) achieving saturation in 3-4 weeks
- Creatine monohydrate is 88% creatine by weight (1.14g monohydrate = 1g pure creatine)
- Response magnitude inversely correlates with baseline stores: vegetarians gain 8-10% strength, omnivores 3-5%
- Brain creatine depletion syndromes (GAMT or AGAT deficiency) cause severe intellectual disability, autism-like symptoms, and epilepsy—rescued by oral creatine supplementation
- Creatine supplementation in older adults combined with resistance training enhances muscle mass gains by 20-40% compared to training alone (critical for sarcopenia prevention)
- ATP — creatine's sole biological function is rapid regeneration of ATP from ADP via phosphocreatine donation, providing immediate energy before glycolysis or Oxidative Phosphorylation can upregulate
- Methylation — creatine synthesis consumes ~40% of SAM-e pool, meaning supplementation spares methylation capacity for neurotransmitters, DNA methylation, and phospholipid synthesis
- Arginine — substrate for first step of creatine synthesis (with glycine), linking creatine to Nitric Oxide synthesis competition for arginine
- Methionine — precursor to SAM-e, the methyl donor required for final creatine synthesis step via GAMT enzyme
- mitochondria — creatine shuttles high-energy phosphate from mitochondrial ATP production site to cytoplasmic utilization sites, acting as spatial energy buffer
- exercise — creatine supplementation improves performance specifically in high-intensity, short-duration work (<30 seconds) where phosphocreatine system dominates
- muscle — primary storage site (95% of body creatine), where phosphocreatine buffers ATP during contraction, particularly in Type II muscle fibres
- cognitive function — brain creatine maintains neuronal ATP under stress (sleep deprivation, hypoxia), with supplementation improving performance in cognitively demanding tasks
- chronic inflammation — creatine provides ATP bypass when mitochondrial dysfunction (from TNF-α, IL-1β) impairs Oxidative Phosphorylation
- sarcopenia — creatine plus resistance training in older adults enhances muscle mass gains by 20-40% compared to training alone
- chronic fatigue syndrome — brain and muscle energy deficit may respond to creatine supplementation, increasing ATP buffer capacity
- traumatic brain injury — acute high-dose creatine (10-20g/day) may provide neuroprotection by maintaining neuronal ATP during metabolic crisis
- vegetarians — have 20-30% lower baseline creatine and show enhanced response to supplementation, with greater strength and cognitive gains than omnivores
- Hunter-Gatherer Phenotype — evolutionary baseline diet provided ~1-2g creatine daily from meat; modern plant-based diets provide zero, creating evolutionary mismatch
- MTHFR — individuals with polymorphisms affecting methylation may benefit doubly from creatine supplementation (sparing limited SAM-e and enhancing energy metabolism)
- BDNF — creatine supplementation upregulates BDNF expression via improved energy status and reduced oxidative stress in hippocampus
- Oxidative Stress — creatine exhibits direct antioxidant effects, scavenging reactive oxygen species and stabilizing mitochondrial membrane potential
- myokines — creatine influences muscle secretome by modulating AMPK and mTORC1 signaling, affecting systemic metabolic health
- Alzheimer's Disease — brain creatine levels decline with age and neurodegeneration; supplementation may slow cognitive decline by supporting neuronal energy metabolism
- Depression — creatine supplementation (5g/day) shows antidepressant effects in women with MDD, possibly via improved brain energy metabolism and methylation sparing
- Module 4 — Creatine as alternative ATP pathway
- Module 5 — Creatine shortens ADP→ATP conversion time
- Module 8 — Creatine synthesis requires methylation (acetic acid → creatine pathway)